| Trovafloxacin | Approved Withdrawn | CDKN1A | 1026 |
upregulated | trovafloxacin results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Trovafloxacin | Approved Withdrawn | DDIT3 | 1649 |
downregulated | trovafloxacin results in decreased expression of DDIT3 mRNA | 12q13.3 | |
| Tubocurarine | Approved Withdrawn | C7 | 730 |
downregulated | Tubocurarine results in decreased expression of C7 mRNA | 5p13.1 | |
| Tubocurarine | Approved Withdrawn | CNTN1 | 1272 |
downregulated | Tubocurarine results in decreased expression of CNTN1 mRNA | 12q12 | |
| Tubocurarine | Approved Withdrawn | CNTN1 | 1272 |
upregulated | Tubocurarine results in increased expression of CNTN1 mRNA | 12q12 | |
| Tubocurarine | Approved Withdrawn | DHFR | 1719 |
downregulated | Tubocurarine results in decreased expression of DHFR mRNA | 5q14.1 | |
| Tubocurarine | Approved Withdrawn | FEZ1 | 9638 |
downregulated | Tubocurarine results in decreased expression of FEZ1 mRNA | 11q24.2 | |
| Tubocurarine | Approved Withdrawn | GOLGA4 | 2803 |
downregulated | Tubocurarine results in decreased expression of GOLGA4 mRNA | 3p22.2 | |
| Tubocurarine | Approved Withdrawn | KMT2C | 58508 |
downregulated | Tubocurarine results in decreased expression of KMT2C mRNA | 7q36.1 | |
| Tubocurarine | Approved Withdrawn | NIN | 51199 |
downregulated | Tubocurarine results in decreased expression of NIN mRNA | 14q22.1 | |
| Tubocurarine | Approved Withdrawn | SOS1 | 6654 |
downregulated | Tubocurarine results in decreased expression of SOS1 mRNA | 2p22.1 | |
| Tubocurarine | Approved Withdrawn | STIP1 | 10963 |
downregulated | Tubocurarine results in decreased expression of STIP1 mRNA | 11q13.1 | |
| Tubocurarine | Approved Withdrawn | UBE2C | 11065 |
downregulated | Tubocurarine results in decreased expression of UBE2C mRNA | 20q13.12 | |
| Tubocurarine | Approved Withdrawn | UBE3A | 7337 |
upregulated | Tubocurarine results in increased expression of UBE3A mRNA | 15q11.2 | |
| Tubocurarine | Approved Withdrawn | ZFR | 51663 |
downregulated | Tubocurarine results in decreased expression of ZFR mRNA | 5p13.3 | |
| Tulobuterol | Investigational | PER1 | 5187 |
upregulated | tulobuterol results in increased expression of PER1 mRNA | 17p13.1 | |
| Urea | Approved Investigational | CPT1A | 1374 |
upregulated | Urea analog results in increased expression of CPT1A mRNA | 11q13.3 | |
| Urea | Approved Investigational | HMOX1 | 3162 |
upregulated | Urea results in increased expression of HMOX1 mRNA | 22q12.3 | |
| Uric acid | Investigational | AGT | 183 |
upregulated | Uric Acid results in increased expression of AGT mRNA | 1q42.2 | |
| Uric acid | Investigational | EDN1 | 1906 |
upregulated | Uric Acid results in increased expression of EDN1 mRNA | 6p24.1 | |
| UDP-alpha-D-glucuronic acid | Experimental | PPARGC1A | 10891 |
upregulated | Uridine Diphosphate Glucuronic Acid results in increased expression of PPARGC1A mRNA | 4p15.2 | |
| Ursodeoxycholic acid | Approved Investigational | ABCB1 | 5243 |
upregulated | Ursodeoxycholic Acid results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Ursodeoxycholic acid | Approved Investigational | ABCB11 | 8647 |
upregulated | Ursodeoxycholic Acid results in increased expression of ABCB11 mRNA | 2q31.1 | |
| Ursodeoxycholic acid | Approved Investigational | ABCC3 | 8714 |
upregulated | Ursodeoxycholic Acid results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Ursodeoxycholic acid | Approved Investigational | APOA1 | 335 |
upregulated | Ursodeoxycholic Acid results in increased expression of APOA1 mRNA | 11q23.3 | |